If you saw Monica Bertagnolli dash around at the Orlando convention center at the annual meeting of the American Association for Cancer Research earlier this week, you would not have guessed that these may be her final days in the NCI director’s job.
The University of Cincinnati Cancer Center was granted $2.3 million from NCI to develop a technique to visualize where genetically modified immune cells go in the body after being administered to patients with cancer.
